Pharmaceuticals Acquisitions in 2014

Acquisition Volume in Pharmaceuticals in 2014 by Year

Last 5 years

Acquisition volume by year Annual acquisition counts for the last 5 years for Pharmaceuticals Acquisitions in 2014. 62 2022 44 2023 55 2024 56 2025 ~59 est. 16 2026
Actual Full-year estimate
  • Buyer
    Nicox S.A.
    Target
    Aciex Therapeutics, Inc.
    Industry
    Pharmaceuticals
    Type
    Buyout

    Nicox S.A. agreed to acquire Aciex Therapeutics, Inc., a U.S.-based ophthalmic development company, in a share-exchange deal that will transfer 100% of Aciex to Nicox. The transaction (approved by Nicox shareholders on October 22, 2014) issues 20,627,024 new Nicox shares for Aciex equity and includes contingent value rights giving up to $55 million in potential additional consideration tied to FDA approvals, and is intended to broaden Nicox's ophthalmic development pipeline.

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.

Related Acquisition Pages